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Introduction
Some of the most severe forms of muscular dystrophy (MD) result from various deficiencies of key muscle-stabilizing proteins within the dystrophin glycoprotein complex (DGC). With the 427 kDa dystrophin protein as its backbone, the DGC provides the framework that connects the cytoskeleton with the extracellur matrix. This large 4 was estimated by performing Xgal staining from sections of tail biopsies and semiquantitative (Q) genomic PCR for both the WT and mutant SGδ genes, as described in (Stillwell et al., 2009; Beck et al., 2011) . We analyzed four mice with <5% ESC incorporation, one mouse with 10% incorporation, two with 40-60% incorporation and two with 60-80% incorporation. Following sacrifice at 18-months of age, the degree of chimerism was reconfirmed via Xgal staining of the older tail biopsies, by semi-Q genomic PCR (Fig. S1 ), and by immunofluorescence (IMF) of the heart for the SGC (Fig. S2Q-T) (Stillwell et al., 2009; Beck et al., 2011) .
WT/SGδ muscle does not show histological corrections with <60% ESC incorporation
We evaluated the histopathological consequences of the ESC treatment in the muscle of 18-month old chimeras. In chimeras with <60% ESC reconstitution, the skeletal muscle (diaphragm, quadriceps and pectoralis) displayed a dystrophic phenotype. Along with a disorganized fiber architecture, these tissues exhibited increases in fibrosis ( Fig. 1G -H, K-L and O-P), central nucleation (Table 1 and Fig. 2G -H, K-L and O-P) and mononuclear invasion relative to WT. With >60% ESC incorporation, the quadriceps and pectoralis both take on a WT-like phenotype, with little or no fibrosis (Fig. 1J and N) , uniform fiber sizes (Fig. 2J and N) , and little or no central nucleation (Table 1 and Fig. 2J and N) . However, the diaphragm is not rescued with >60% ESC incorporation as still showed fibrosis ( Fig. 1F ) and increased central nucleation (Table 1 and Fig. 2F ) relative to WT, but less mononuclear invasion than <60% chimeric diaphragm (Fig. 2F , compare to Fig. 2G ).
Unlike the skeletal muscle, the heart does not syncytialize. However, similar to the pectoralis and quadriceps, the heart is also rescued with >60% ESC mosaicism (Fig. 1B for interstitial fibrosis and 2B for mononuclear invasion), although fibrosis at the periphery of the blood vessels still remained (Fig. 1B, compare to 1A ). This cardiac improvement is supported by functional echocardiogram data (ejection fraction (EF) of 40-60%, 10-20% and <5% WT/SGδ hearts): 58.2±3.97 (n=6) relative to EF of 60-80% WT/SGδ and WT hearts: 68.3±6.45 (n=4)(Values are means ± SEM; P<0.05)).
The skeletal muscle but not the heart of 60-80% WT/SGδ chimeras has uniform
SGC distribution
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We ascertained whether ESCs restore the SGC in skeletal muscle and heart. SGδ KO mice have shown complete ablation of the SGC with no residual sarcoglycan expression (Hack et al., 2000; Draviam et al., 2006) . Similar to SGδ KO, IMF analysis showed a lack of expression of SGβ and SGα in the <5% chimeras (Fig. S2D , H, L, P and T). In 40-60% WT/SGδ chimeras, clusters of SGα and SGβ positive cardiomyocytes and skeletal muscle fibers appear indicating the reinstatement of the SGC, albeit in patches throughout the tissue (Fig. S2C , G, K, O and S). When the ESC incorporation is increased in the 60-80% WT/SGδ chimeras, the SGC is uniformly restored near or at WT levels in the skeletal muscle (Fig. S2B, F, J, N,) . However, the heart (non-syncytium) of 60-80% WT/SGδ chimeras had few patches of muscle unstained (Fig. S2R ). In spite of the absence of unstained areas for the SGC of 60-80% diaphragm (Fig. S2J, N) , this muscle had dystrophic features ( Fig. 1F and Fig. 2F ).
We determined that SGδ protein levels in the chimeric muscle also correlated with the observed SGC restoration. There was a recovery of SGδ in the 60-80% chimeras and in a lesser extent in the <60% chimeras, although there was a noticeable protein band just below the normal SGδ band (Fig. 3A-D) . This lower molecular weight band is more prominent in 60-80% chimeras than in WT.
The WT/SGδ chimera diaphragm shows decreased dystrophin levels but no utrophin upregulation Dystrophin has previously been found to be unaffected by the loss of the SGC (Hack et al., 2000; Li et al., 2009 ). In our previous models with mdx mice, there was a noticeable lack of uniformity of dystrophin-positive fibers within the rescued muscle (Stillwell et al., 2009; Beck et al., 2011) . However, in WT/SGδ chimeras, dystrophin was detected in all fibers, but its overall staining intensity appeared to vary (Fig. 4) . In the pectoralis, there appeared to be minimal changes in dystrophin staining intensity in WT, KO and chimeras, irrespective of the degree of mosaicism (Fig. 4A-D) . Contrary to that, IMF in the diaphragm displayed a gradual reduction in the staining intensity of dystrophin, although there was some residual dystrophin staining in every fiber ( Fig. 4E-H ). Western blot (WB) analysis also showed this observed dystrophin reduction in the diaphragms of the chimeras (Fig. 3C) . Decreases in dystrophin expression in the diaphragm were as large as 12.5-fold when comparing WT with the <5% chimeras ( Fig. 6A-B) , the diaphragm showed a compromise in the levels of dystrophin, but not syntrophin ( Fig. 3C, Fig. 6C ). Thus, nNOS levels were compromised in the SGδ KO and SGδ non-rescued chimeras irrespective of the lack of changes observed in dystrophin or syntrophin levels.
Although the heart showed reduction in the levels of SGδ in the chimeras (Fig. 3D) , there was no significant reduction in the levels of dystrophin, syntrophin or nNOS (Fig. 3D,   6D ). The lack of a compromise observed in nNOS levels could likely be attributed to the lack of significant DGC disruption, or to the presence of nNOS isoforms not directly associated with the DGC in cardiac tissue (Li et al., 2010; Percival et al., 2010) , in contrast to the main sarcolemmal nNOS found in skeletal muscle (Mungrue and Bredt, 2004) .
Discussion
We have shown that it takes over 60% WT ESC chimerism for the rescue of all but the diaphragm from LGMD-2F mice. However, in previous reports, we showed that it takes about 10-30% ESC (or iPSC) incorporation to rescue mdx mice, which are predisposed to DMD (Stillwell et al., 2009; Beck et al., 2011) . This disparity could be linked to several Likewise, the ESCs may over-produce dystrophin in mdx (Stillwell et al., 2009) but not in SGδ. The mdx mouse shows histological lesions typical of MD, but muscular wastage proceeds in a much milder fashion compared to human DMD (Willmann et al., 2009 ).
These differences between humans and mice have been attributed in part to an increased regenerative capacity of muscle in mice (Pastoret and Sebille, 1995; Sacco et al., 2010) .
In mdx and DMD, dystrophin-deficient tissues are partially compensated through the upregulation of the dystrophin homologue utrophin, however inefficiently (Deconinck et al., 1997) , and mouse muscle without dystrophin and utrophin cannot be rescued with low WT pluripotent stem cell chimerism (Beck et al., 2011) . Utrophin is overexpressed in the sarcolemma of mdx mice, but not in SGδ KO mice (Li et al., 2009) or WT/SGδ chimeras (Fig. 5) . Consequently, when dytrophin levels decrease in the diaphragm of the WT/SGδ chimeras, there is no utrophin to help compensate the muscle. Unlike mdx tissue, there is residual dystrophin in the fibers of our WT/SGδ chimeras. This threshold of residual sarcolemmal dystrophin is likely sufficient enough to negatively inhibit utrophin upregulation, as sarcolemmal dystrophin inhibits sarcolemmal utrophin (Beck et al., 2011) . Lack of SGδ, combined with dystrophin reduction and absence of sarcolemmal utrophin would cause the tissue to be highly susceptible to stress-induced damage, mononuclear invasion and fibrosis.
In all the four chimeric tissues we examined, we observed that there were double bands, approximately 35 kDa, for SGδ. This is consistent with the fact that there are several SGδ isoforms in skeletal muscle and fat (Estrada et al., 2006; Groh et al., 2009 ). However, this finding contrasts with previous published data (Li et al., 2009) showing one major band for SGδ, although the previous studies were performed with muscle from non-aging mice. We believe that the use of a gradient polyacrylamide gel also contributes to the resolution of SGδ isoforms in the range of 30-40 kDa. While the higher molecular weight band roughly paralleled the degree of mosaicism, the lower molecular weight band was more prominent in the chimeric than in the WT tissue. We showed that a number of dystrobrevin products were prevalent in a non-dystrophic state, and a number of dystrobrevin products were prevalent in a dystrophic state (Stillwell et al., 2009 ). An Journal of Cell Science Accepted manuscript 8 association of SGδ products with a chimeric/dystrophic state has not been reported before. The prevalence of a lower (potentially inactive or partially active) molecular weight SGδ product in chimeras could also help explain why more ESC chimerism is needed for correction in SGδ KO than in mdx. We have previously reported the induction of neomorphic effects in chimeras due to novel interactions between WT and mutant environment (Fraidenraich et al., 2004; Zhao et al., 2010) . This switch in the pattern of high versus low SGδ molecular weight bands may represent another example of a neomorphic process. Whether this banding pattern corresponds to previously identified functional SGδ isoforms (Estrada et al., 2006) , or whether it corresponds to novel products, it remains to be elucidated.
In skeletal muscle, nNOS which produces nitric oxide, is involved with many downstream effects, including vasodilation, muscle contractility, Ca 2+ release and glucose uptatke (Stamler and Meissner, 2001; Percival et al., 2010; Li et al., 2011) . Several mechanisms have been postulated for the association of nNOS with the DGC. One is the PDZ domain observed in both nNOS and α1-syntrophin (Adams et al., 2001) . Another is the spectrin-like repeats 16 and 17 in the rod domain of dystrophin (Lai et al., 2009 ). In the absence of these domains, nNOS fails to be recruited to the sarcolemma, and may be mislocalized and degraded. In the presence of a dystrophic environment high calcium may supra-activate the enzyme (Zhou and Zhu, 2009) present in the non-rescued chimera, which in turn may produce undesirable reactive nitrogen species (RNS), to ultimately alter important downstream processes (Rando, 2001a; Li et al., 2011) . This detrimental process may continuously lead to a more pronounced dystrophic environment. It is important to point out that syntrophin levels were not compromised in any muscle analyzed. While dystrophin reduction can explain nNOS reduction in the diaphragm, the disruption or improper localization of other members (i.e. sarcoglycan/dystroglycan loss or syntrophin mislocalization) may have to account for the reduction of nNOS in quadriceps or pectoralis.
It has been previously reported that there are no decreases in dystrophin levels in SGδ or other sarcoglycan KO mouse models (Hack et al., 2000; Li et al., 2009 ). Here we report, however, that the lack of the SGC (directly or indirectly) triggers decreases in dystrophin levels in specific muscles. This occurs primarily in the diaphragm, which has a unique Journal of Cell Science Accepted manuscript 9 tissue architecture and a mixed composition of both slow-and fast-twitch fiber types (Kobzik et al., 1994) . Moreover, the age of the WT/SGδ chimeras (18-months) may have exacerbated the dependence of dystrophin to the SGC (the age of the examined muscles is relevant to LGMD-2F, as patients do not die in the teens as in the case of DMD (Durbeej and Campbell, 2002; Laval and Bushby, 2004) ). With a severe compromise in dystrophin and no compensatory utrophin, the pathology of the diaphragm in LGMD-2F
would become more severe. This severe phenotype in turn, may detrimentally impinge on the presence of dystrophin (i.e. decreased production or increased destruction), to further intensify the muscle damage. Thus, the presence of the dystrophic fibers, due to a SGCdeficient environment, may produce an amplified destructive process via dystrophin reduction. This cascading scenario may ultimately lead to increased resistance to ESC treatment. We cannot formally rule out, however, the opposite scenario, in which the severe phenotype acts as the primary trigger for the observed decreases in dystrophin.
Nevertheless, the study shows a tight correlation between dystrophy and dystrophin reduction in specific muscles of the SGδ KO.
In conclusion, we describe here that, unlike mdx, the SGδ KO model is not amenable to ESC-treatment, particularly the diaphragm. Our results argue against the concept that every MD paradigm may be easily treatable with ESCs. Furthermore, the syncytial nature of the skeletal muscle may be regarded as a facilitator for DGC reconstitution in ESC therapy, but this prevailing concept may have to be revisited, because the SGδ KO heart, which does not syncytialize, requires a similar (high) threshold for ESC correction than that of the SGδ KO pectoralis/quadriceps.
Materials and Methods
Embryonic Stem Cells
WT LacZ-marked Rosa 26 (R26) mouse ESCs were provided by Phillipe Soriano (Mount Sinai School of Medicine, NY, NY). R26 ESCs grow in KO-DMEM, 15% ESC-grade FBS, 1% glutamine, 1% penicillin/streptomycin, 1% non-essential amino acids, 1%
nucleosides, β-mercaptoethanol and leukemia inhibitory factor (LIF). ESCs are cultured on top of murine embryonic fibroblasts in a gelatin-coated plate.
Generation of chimeric mice
Journal of Cell Science Accepted manuscript 3-week old SGδ KO females were superovulated via intraperitoneal injection with chorionic gonadotrophin and gonadotrophin (Calbiochem, Darmstadt, Germany), three days and one day, respectively, before mating with SGδ KO stud males. After 3.5 days, the females were sacrificed and the uteri were flushed in order to collect blastocysts.
Each blastocyst was then microinjected with 12-15 WT R26 ESCs. Then the chimeric blastocysts were implanted into the uteri of pseudopregnant surrogate females and the pregnancy was allowed to develop to term. All mice were sacrificed at 18-months of age.
All animal experiments were conducted under accordance and with the approval by the Institutional Animal Care and Use Committee (IACUC) of the University of Medicine and Dentistry of New Jersey.
Western blotting
Tissue was homogenized in lysis buffer and protein concentrations were determined using the BCA™ Protein Assay Kit (Thermo Scientific, Rockford, IL). Values obtained from WT samples were arbitrarily assigned values of 1.
Immunofluorescence & X-gal histochemistry
Mice were sacrificed at 18-months of age and tissues were harvested. Samples were OCT embedded and then cryosectioned (10µm). For immunofluorescence, the cryosections were stained with antibodies specific for dystrophin (1:20, dys2,
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Novocastra, Leica Microsystems, Buffalo Grove, IL), sarcoglycan-α (1:200, Novocastra, Leica Microsystems, Buffalo Grove, IL) and sarcoglycan-β (1:200, Novocastra, Leica
Microsystems, Buffalo Grove, IL). Cryosections were also used for X-gal histochemistry. The X-gal staining solution consists of 1 mg/ml of X-gal in PBS buffer containing 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 2 mM MgCl 2 . Slides were incubated overnight at 37°C and then eosin counterstained the next day.
Histology
Chimeric and control mice were sacrificed at 18-months of age and tissues were harvested. Samples were fixed in 4% PFA and embedded before undergoing hematoxylin and eosin (H&E) and Masson trichrome (MT) staining. Digital images of skeletal and cardiac muscle sections were derived from a camera attached to an upright microscope. Central nucleation calculations were produced from counting fibers that were centrally nucleated on multiple H&E sections (n) of pectoralis, quadriceps and diaphragms. Sections from similar areas of the tissues were chosen for a more accurate assessment.
Semi-quantitative genomic PCR
Genomic DNA from all chimeras, WT and SGδ controls was isolated from tail snips by overnight digestion in SDS/Proteinase K buffer followed by phenol/chloroform extraction. 50ng of genomic DNA was used in PCR with primers for genotyping the WT 
Statistical Analysis
Data are presented as a mean ± standard error of mean (s.e.m. WT/SGδ and mdx mice were subjected to western blot for dystrophin, SGδ, and tubulin Abbreviations: Dys: dystrophin; Tub: tubulin; SGδ: sarcoglycan-δ. 
